Key facts
- This page summarizes Patricia Eckert's Form 4 filing for ENZO BIOCHEM INC (ENZB).
- 6 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 20 Aug 2025, 08:27.
Patricia Eckert - 20 Aug 2025 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ENZB
- Reported as of
- 20 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Aug 2025, 08:27:26 UTC
- Prior SEC filing
- 25 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patricia Eckert
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Patricia Eckert filed Form 4 for ENZO BIOCHEM INC (ENZB) on 20 Aug 2025.
Change
- Previous filing in this sequence was filed on 25 Jul 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001952777
Primary reporting owner
Eckert Patricia
- Relationship
- Chief Financial Officer
- Address
- C/O ENZO BIOCHEM, INC., 21 EXECUTIVE BLVD., FARMINGDALE
- Signature
- /s/ Patricia Eckert
- Signature date
- 20 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENZB
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -28,328
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- 401k
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ENZB
transaction
Derivative
Stock Option (to acquire shares of Common Stock)
Disposed to Issuer
- Transaction value
- Shares
- -100,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- Footnotes
- F2
ENZB
transaction
Derivative
Stock Option (to acquire shares of Common Stock)
Disposed to Issuer
- Transaction value
- Shares
- -75,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- Footnotes
- F2
ENZB
transaction
Derivative
Stock Option (to acquire shares of Common Stock)
Disposed to Issuer
- Transaction value
- Shares
- -25,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F2
ENZB
transaction
Derivative
Stock Option (to acquire shares of Common Stock)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F2
ENZB
transaction
Derivative
Stock Option (to acquire shares of Common Stock)
Disposed to Issuer
- Transaction value
- Shares
- -25,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Patricia Eckert is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
Footnote F2
Pursuant to the Merger Agreement, at the Effective Time, each option that was outstanding as of immediately prior to the Effective Time was automatically, and without any required action on the part of the Reporting Person, canceled without any cash payment or other consideration being made in respect thereof.